MARKET PULSE JPMorgan Chase & Co. (JPM) CEO Jamie Dimon and Treasury Secretary Jamie Dimon hatched the $30 billion, 11-bank plan to inject deposits into First Republic Bank (FRC) in a phone call on Tuesday, according to reports in The Wall Street Journal and other publications.
Stephen Schwartzman, worth $42 billion and at the head of a firm managing almost $1 trillion, says social media is what doomed the bank.
Investors looking for alpha in an uncertain market environment could do worse than following in the footsteps of legendary stock pickers and probably none can match Warren Buffet’s reputation. Not for nothing the “Oracle of Omaha” is considered one of the all-time greats and for nearly 60 years, between 1965 and 2022, his Berkshire Hathaway firm’s returns have doubled those of the S&P 500. So, it’s definitely worth nosing through Buffett’s portfolio to see which stocks he currently holds. And wh
Rich Day Company co-founder Robert Kiyosaki dissects why he foresees the Bank of Japan collapsing and the potential implications it could have on the global economy.
Here are some of today's after-hours movers.
For most people, it will be little or no problem to retire at age 65 if they have $2.5 million in savings. This amount of capital invested prudently is likely to provide sufficient income for a lifestyle comfortable enough to … Continue reading → The post Is $2.5 Million Enough to Retire at 65? appeared first on SmartAsset Blog.
The Nasdaq topped 12,000 as the market rallied ahead of the PCE inflation report. The IRS will likely cut EV credits for Tesla's entry-level Model 3.
The semiconductor maker brings forward timelines for production of next-generation data-center chips.
T. Rowe Price fixed-income manager Cheryl Mickel identifies the best spots to park short-term cash, how to navigate the banking sector, and where the Federal Reserve may be going next.
Elon Musk doesn't seem all that impressed with Warren Buffett's stock picks. And he took to Twitter — of course — to say so.
There’s no doubt, these are challenging times for Lucid Group (NASDAQ:LCID). The luxury EV maker recently announced it will layoff around 1,300 employees – around 18% of its global workforce. The cull is part of the company’s aim to get laser focused on lowering cash burn, amidst restructuring efforts. The workforce reductions are expected to be completed by the end of Q2. Lucid’s issues don’t end there. The company has seen dwindling demand for its luxury electric sedans – priced at a starting
The Dow Jones rose 175 points Thursday after first-time jobless claims and Q4 GDP data. Schwab stock dropped on an analyst downgrade.
(Bloomberg) -- Tesla Inc. is looking to build a battery plant in the US, according to people familiar with the matter, in what would likely be a controversial arrangement with China’s dominant electric-vehicle battery manufacturer.Most Read from BloombergTrump Faces Fingerprints, Mug Shot After Dramatic IndictmentSingapore’s Changi Sees Immigration System Restored After Delays$335,000 Pay for ‘AI Whisperer’ Jobs Appears in Red-Hot MarketA $3 Trillion Threat to Global Financial Markets Looms in J
AT&T stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
If you were to judge ASML stock from its sales and earnings, it would be hard to believe it belongs in the IBD Big Cap 20. FactSet data shows a mix of gains and declines in quarterly performance for the Netherlands-based chip equipment provider. The consensus estimate for first-quarter earnings is €20.06 per share, an increase of more than 30% from a forgettable 2022.
The firm said it was relocating “immediately” from Washington after the state’s supreme court cleared the way for a capital gains tax on individuals.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Distressed retailer warns it would likely file for bankruptcy if it is unable to tap retail market for funding.
The chief executive of HSBC has been accused of pressuring the bank’s staff to give a £40m loan to the real estate company his daughter worked at.
The economy and inflation could slow without the need for many more interest rate hikes—and it would be good news for stocks.
It’s been a good week for investors of Pyxis Oncology (NASDAQ:PYXS), to say the least. Over the past 4 sessions Pyxis shares have gained 170%, bringing the year-to-date haul to a mighty 340%. This biotech micro-cap is backed by Pfizer, which is largely responsible for the recent rally. According to a recent SEC filing, the pharma giant loaded up on 1,811,594 PYXS shares earlier this month for a total sum of $5 million, paying $2.76 per share. This raised Pfizer’s ownership in Pyxis to 5,952,263
Yahoo Finance 
Yahoo Finance Plus